Talha Badar and Team: New VTE Risk Prediction Model Validated for Asparaginase-Treated ALL
Talha Badar, Hematologist-Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X:
”Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Happy to contribute in this effort by ALL NCTN:
High VTE rates persist in asparaginase-treated ALL despite prophylaxis.
Externally validated VTE risk model using D-dimer and hemoglobin at diagnosis.”
Read the full article here.
Title: Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Authors: Daniela R. Anderson, Radhika Gangaraju, Wafik G. Sedhom, Eva N. Hamulyák, Tzu-Fei Wang, Kristen M O’Dwyer, Brian J. Carney, Chandrasekar Muthiah, Michaela Liedtke, Talha Badar, Shai Shimony, Renana Robinson, Kristen Sanfilippo, Andriy Derkach, Shira Naomi Dinner, Bart J. Biemond, David Nemirovsky, Leah A. Goldberg, Anjani D. Kapadia, Hannah Levavi, Michal Bar-Natan, Grace Van Hyfte, Karan Bansal, Marc Carrier, Jill Fulcher, Anke M. Gerrits, Mark R. Litzow, Selina M Luger, Guru Subramanian Guru Murthy, Marlise R. Luskin, Ofir Wolach, William Shomali, Jeffrey I. Zwicker, Wendy A Stock, Avi Leader
Stay updated with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 8, 2025, 01:40Mikhail Fominykh: What I Read This Week
-
Nov 8, 2025, 01:40Shubham Khandve: Cell and Gene Therapy is No Longer the Future
-
Nov 8, 2025, 01:39World Federation of Hemophilia: Hemophilia Care is Evolving
-
Nov 8, 2025, 01:38Muhammad Awidi – Choking Growth One Puff at a Time: How Tobacco is Strangling Jordan’s Economy
-
Nov 8, 2025, 01:38Abdul Mannan Inside the Diagnostic Maze of Atypical CML
-
Nov 8, 2025, 01:37Steven Murphy Discusses Peptides in Orthobiologic Medicine at AMSKU 2025
-
Nov 8, 2025, 01:37Cellfie of the Day: Classic Gaucher Cells Under the Microscope